Sponsor:Johns Hopkins UniversityBrief Summary: FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) target the relapsing phase of MS but have minimal…
Sponsor:University of California, San FranciscoBrief Summary: Many people with MS report sleep disturbances. However, objective data on sleep quality in…
Sponsor:University of California, San FranciscoBrief Summary: The goal is to investigate the effects of non-invasive transcranial electrical stimulation on cognition…
Sponsor:Hoffmann-La RocheBrief Summary: This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple…
Sponsor:National Institute of Allergy and Infectious Diseases (NIAID)Brief Summary: This is a multi-center prospective rater-masked (blinded) randomized controlled trial of…
Sponsor:The Cleveland ClinicBrief Summary: The need for improved diagnostic methods in Multiple Sclerosis (MS) is widely recognized. Although Magnetic Resonance…
Sponsor:University of California, San FranciscoBrief Summary: In this Phase 1b open-label prospective clinical trial, patients with relapsing-remitting MS will undergo…
Sponsor:Berkovich, Regina MD, PhD Inc.Brief Summary: This is an open-label study of patients with relapsing forms of MS is designed…
Sponsor:Hoffmann-La RocheBrief Summary: This is a randomized, double blind, controlled, parallel group, multicenter study to evaluate efficacy, safety and pharmacokinetics…
Sponsor:Novartis PharmaceuticalsBrief Summary: To assess safety and tolerability of patients converting from approved Relapsing Multiple Sclerosis (RMS) Disease Modifying Therapies…
